ATYPICAL INDUCTIVE PROPERTIES OF RIFAMPICIN

被引:22
作者
HEUBEL, F
NETTER, KJ
机构
[1] Institut für Pharmakologie und Toxikologie, Lahnberge, Philipps-Universität
关键词
D O I
10.1016/0006-2952(79)90075-3
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Hepatic and microsomal parameters, metabolism of cytochrome P-450-dependent substrates and spectral properties of cytochrome P-450 have been used in mice in order to classify rifampicin as an inducer by comparing it to phenobarbitone and 3-methylcholanthrene. Rifampicin significantly enhanced relative liver weight, cytochrome P-450 content, microsomal protein, weight of the 100,000 g pellet and shortened the zoxazolamine paralysis time. Compared on the basis of microsomal protein, of five substrate reactions only the ethylmorphine demethylation was enhanced; ethoxycoumarin deethylation and biphenyl 1-2-hydroxylation were unaltered; ethoxyresorufin de-ethylation and biphenyl-4-hydroxylation were decreased. The CO-cytochrome P-450 absorption maximum showed a blue shift of about 0.5 nm after only 1 day of rifampicin pretreatment, while there was no significant blue shift after 1 day of 3-methylcholanthrene pretreatment. Rifampicin has been shown to be an inducer in NMRI mice. Although resembling phenobarbitone it seems, however, to be a similarly atypical inducer as it is in man. © 1979.
引用
收藏
页码:3373 / 3378
页数:6
相关论文
共 39 条
[1]   KINETICS OF RIFAMPICIN AND ISONIAZID ADMINISTERED ALONE AND IN COMBINATION TO NORMAL SUBJECTS AND PATIENTS WITH LIVER-DISEASE [J].
ACOCELLA, G ;
BONOLLO, L ;
TENCONI, LT ;
GARIMOLDI, M ;
MAINARDI, M ;
NICOLIS, FB .
GUT, 1972, 13 (01) :47-+
[2]   SIMPLE AND SENSITIVE ASSAY OF 7-ETHOXYCOUMARIN DEETHYLATION [J].
AITIO, A .
ANALYTICAL BIOCHEMISTRY, 1978, 85 (02) :488-491
[3]  
BERETTA E, 1972, 1972 RIUN MON IND EN
[4]  
BINDA G, 1971, ARZNEIMITTELFORSCH, V21, P1908
[5]  
BOEKHOUTMUSSERT MJ, 1974, JAMA-J AM MED ASSOC, V229, P1903
[6]   EFFECT OF RIFAMPICIN TREATMENT ON METABOLISM OF ESTRADIOL AND 17 ALPHA-ETHINYLESTRADIOL BY HUMAN LIVER-MICROSOMES [J].
BOLT, HM ;
KAPPUS, H ;
BOLT, M .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1975, 8 (05) :301-307
[7]  
BOLT HM, 1977, ACTA ENDOCRINOL-COP, V85, P189
[8]  
BREIMER DD, 1977, CLIN PHARMACOL THER, V21, P470
[9]  
BRUNING JL, 1968, COMPUTATIONAL HDB ST
[10]  
BURKE MD, 1974, DRUG METAB DISPOS, V2, P583